Senti Biosciences, Inc.
SNTI
$1.65
$0.0553.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.73M | -14.11M | -610.00K | -28.87M | -11.20M |
| Total Depreciation and Amortization | 914.00K | 926.00K | 1.46M | 1.46M | 971.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.57M | 1.20M | -12.89M | 16.49M | -1.03M |
| Change in Net Operating Assets | -819.00K | -2.07M | -1.46M | 3.05M | 2.92M |
| Cash from Operations | -13.07M | -14.05M | -13.50M | -7.87M | -8.35M |
| Capital Expenditure | -196.00K | -- | -11.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 12.00K | -- | 0.00 | 60.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -184.00K | -- | -11.00K | 60.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 534.00K | -- | 49.05M | 10.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 477.00K | -414.00K | 2.24M | 2.43M | -- |
| Cash from Financing | 1.01M | -414.00K | 51.29M | 2.44M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.25M | -14.46M | 37.78M | -5.37M | -8.35M |